Advertisement
BDRX vs FRMM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDRX is a StrongBuy and FRMM is a Hold.
Momentum Indicator for BDRX turns negative, indicating new downward trend
BDRX saw its Momentum Indicator move below the 0 level on September 25, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 94 similar instances where the indicator turned negative. In 93 of the 94 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for BDRX entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BDRX's RSI Oscillator exited the oversold zone, 41 of 54 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 64 cases where BDRX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Moving Average Convergence Divergence (MACD) for BDRX just turned positive on October 15, 2026. Looking at past instances where BDRX's MACD turned positive, the stock continued to rise in 33 of 45 cases over the following month. The odds of a continued upward trend are 73%.
Following a +0.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where BDRX advanced for three days, in 131 of 176 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
BDRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.045) is normal, around the industry mean (3.043). P/E Ratio (-0.017) is within average values for comparable stocks, (-1.361). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (133.535) among similar stocks. P/S Ratio (10.977) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. BDRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BDRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Momentum Indicator for FRMM turns negative, indicating new downward trend
FRMM saw its Momentum Indicator move below the 0 level on October 05, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 85 similar instances where the indicator turned negative. In 78 of the 85 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Moving Average Convergence Divergence Histogram (MACD) for FRMM turned negative on October 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 39 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FRMM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for FRMM entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +3.58% 3-day Advance, the price is estimated to grow further. Considering data from situations where FRMM advanced for three days, in 178 of 206 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
FRMM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.349) is normal, around the industry mean (-1.896). P/E Ratio (-0.066) is within average values for comparable stocks, (15.157). Projected Growth (PEG Ratio) (2.780) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.075) among similar stocks. P/S Ratio (7.246) is also within normal values, averaging (71.128).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. FRMM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FRMM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
BDRX | FRMM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 93 | 54 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 49 Fair valued | 61 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 100 | |
PRICE GROWTH RATING 1..100 | 96 | 89 | |
P/E GROWTH RATING 1..100 | 6 | 11 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BDRX's Valuation (49) in the Biotechnology industry is in the same range as FRMM (61) in the Financial Conglomerates industry. This means that BDRX’s stock grew similarly to FRMM’s over the last 12 months.
BDRX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FRMM (100) in the Financial Conglomerates industry. This means that BDRX’s stock grew similarly to FRMM’s over the last 12 months.
BDRX's SMR Rating (97) in the Biotechnology industry is in the same range as FRMM (100) in the Financial Conglomerates industry. This means that BDRX’s stock grew similarly to FRMM’s over the last 12 months.
FRMM's Price Growth Rating (89) in the Financial Conglomerates industry is in the same range as BDRX (96) in the Biotechnology industry. This means that FRMM’s stock grew similarly to BDRX’s over the last 12 months.
BDRX's P/E Growth Rating (6) in the Biotechnology industry is in the same range as FRMM (11) in the Financial Conglomerates industry. This means that BDRX’s stock grew similarly to FRMM’s over the last 12 months.
| BDRX | FRMM | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 76% | 1 day ago 81% |
| Stochastic ODDS (%) | 1 day ago 81% | 1 day ago 85% |
| Momentum ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 73% | 1 day ago 89% |
| TrendWeek ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Advances ODDS (%) | 27 days ago 74% | about 1 month ago 86% |
| Declines ODDS (%) | 5 days ago 90% | 5 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 87% | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDRX’s FA Score shows that 1 FA rating(s) are green while FRMM’s FA Score has 1 green FA rating(s).
- BDRX’s FA Score: 1 green, 4 red.
- FRMM’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDRX’s TA Score shows that 5 TA indicator(s) are bullish while FRMM’s TA Score has 4 bullish TA indicator(s).
- BDRX’s TA Score: 5 bullish, 3 bearish.
- FRMM’s TA Score: 4 bullish, 4 bearish.
Price Growth
BDRX (@Biotechnology) experienced а -7.19% price change this week, while FRMM (@Packaged Software) price change was -5.59% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was -16.30%, and the average quarterly price growth was -16.78%.
The average weekly price growth across all stocks in the @Packaged Software industry was +2.68%. For the same industry, the average monthly price growth was -3.56%, and the average quarterly price growth was +4.53%.
Reported Earning Dates
FRMM is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Biotechnology (+1.24% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
@Packaged Software (+2.68% weekly)Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
Advertisement
FRMM and
Correlation & Price change
A.I.dvisor indicates that over the last year, FRMM has been loosely correlated with WVE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if FRMM jumps, then WVE could also see price increases.
| Ticker / NAME | Correlation To FRMM | 1D Price Change % | ||
|---|---|---|---|---|
| FRMM | 100% | +1.50% | ||
| WVE - FRMM | 44% Loosely correlated | -5.07% | ||
| PRQR - FRMM | 44% Loosely correlated | -3.01% | ||
| JSPR - FRMM | 41% Loosely correlated | +2.91% | ||
| PHUN - FRMM | 40% Loosely correlated | -0.51% | ||
| MSTR - FRMM | 38% Loosely correlated | +0.14% | ||
More | ||||